Page last updated: 2024-09-05

lapatinib and ici 118551

lapatinib has been researched along with ici 118551 in 1 studies

Compound Research Comparison

Studies
(lapatinib)
Trials
(lapatinib)
Recent Studies (post-2010)
(lapatinib)
Studies
(ici 118551)
Trials
(ici 118551)
Recent Studies (post-2010) (ici 118551)
1,9193051,44219010

Protein Interaction Comparison

ProteinTaxonomylapatinib (IC50)ici 118551 (IC50)
Beta-2 adrenergic receptorHomo sapiens (human)0.0017
Alpha-2A adrenergic receptorHomo sapiens (human)0.0005

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dahal, A; Gu, X; Jois, S; Mattheolabakis, G; Singh, SS; Withers, S1

Other Studies

1 other study(ies) available for lapatinib and ici 118551

ArticleYear
A grafted peptidomimetic for EGFR heterodimerization inhibition: Implications in NSCLC models.
    European journal of medicinal chemistry, 2021, Apr-15, Volume: 216

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Dimerization; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Humans; Lung Neoplasms; Mice; Mice, Nude; Peptides; Peptidomimetics; Phosphorylation; Protein Interaction Domains and Motifs; Protein Kinase Inhibitors; Transplantation, Heterologous

2021